Analyst Ratings published Thursday July 3rd 2025

7/3/25	Resumed	Overweight	X
ABSI Absci Corporation Morgan Stanley
$7
7/3/25	Resumed	Overweight	X
ARGX argenx Morgan Stanley
$700
7/3/25	Resumed	Overweight	X
ASND Ascendis Pharma Morgan Stanley
$250
7/3/25	Resumed	Overweight	X
AXSM Axsome Therapeutics Morgan Stanley
$190
7/3/25	Resumed	Overweight	X
BMRN BioMarin Pharmaceutical Morgan Stanley
$97
7/3/25	Reiterated	Buy	X
CCK Crown Citigroup
$119 $129
7/3/25	Resumed	Equal-Weight	X
CERT Certara Morgan Stanley
$16
7/3/25	Reiterated	Buy	X
DD DuPont Citigroup
$75 $85
7/3/25	Upgrades	Underperform Outperform	X
FDX FedEx BNP Paribas Exane
$270
7/3/25	Upgrades	Peer Perform Outperform	X
HBAN Huntington Banc Wolfe Research
$21
7/3/25	Resumed	Overweight	X
IRON Disc Medicine Morgan Stanley
$85
7/3/25	Resumed	Overweight	X
KYMR Kymera Therapeutics Morgan Stanley
$70
7/3/25	Upgrades	Underperform Hold	X
META Meta Platforms Needham
7/3/25	Downgrades	Buy Hold	X
NVEE NV5 Global Maxim Group
7/3/25	Downgrades	Outperform Peer Perform	X
PNC PNC Wolfe Research
7/3/25	Initiated	Buy	X
PRIM Primoris Services Janney
7/3/25	Downgrades	Buy Hold	X
RIO Rio Tinto Berenberg
7/3/25	Resumed	Equal-Weight	X
RXRX Recursion Pharmaceuticals Morgan Stanley
$5
7/3/25	Resumed	Overweight	X
SANA Sana Biotechnology Morgan Stanley
$12
7/3/25	Resumed	Equal-Weight	X
SDGR Schrodinger Morgan Stanley
$28
7/3/25	Downgrades	Mkt Outperform Mkt Perform	X
TWO Two Harbors Investment Citizens JMP
7/3/25	Upgrades	Underperform Neutral	X
UPS UPS BNP Paribas Exane
$100
7/3/25	Upgrades	Eq-Weight Overweight	X
VLY Valley National Morgan Stanley
$11